Company Filing History:
8 out of 4,125 
1 out of 832,843 Years Active: 1986-2006
Title: The Innovative Contributions of Charles E Elson
Introduction
Charles E Elson is a notable inventor based in Madison, WI (US), recognized for his significant contributions to the field of cancer treatment. With a total of 9 patents to his name, Elson has dedicated his career to developing innovative solutions aimed at impeding cancer cell growth.
Latest Patents
Among his latest patents, Elson has developed a composition and method for treating cancer. This innovative composition includes at least a first and a second HMG-CoA reductase inhibitor, which work synergistically to impede cancer cell growth. The method involves treating cancer cells with this composition, which has shown effectiveness in surpassing the theoretical additive effects of the individual inhibitors. Another notable patent involves acyclic isoprenoid ether derivatives as chemotherapeutics. This method focuses on suppressing tumor cell growth in patients through the use of isoprenoid ether-linked compounds, demonstrating Elson's commitment to advancing cancer treatment methodologies.
Career Highlights
Throughout his career, Charles E Elson has been associated with the Wisconsin Alumni Research Foundation, where he has contributed to various research initiatives. His work has been pivotal in the development of new therapeutic approaches for cancer treatment, showcasing his expertise and dedication to medical innovation.
Collaborations
Elson has collaborated with esteemed colleagues such as Huanbiao Mo and Michael N Gould, further enhancing the impact of his research and inventions in the field of oncology.
Conclusion
Charles E Elson's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. His patents and collaborations reflect a commitment to improving patient outcomes through groundbreaking research and development.